Because an increased risk of bleeding
and kidney damage has been seen in
similar medications, individuals taking
SPINRAZA may be at similar risk.
It is recommended that your
healthcare provider (HCP) perform
blood and urine testing once before
treatment and again before each dose
to monitor for signs of these risks.
In clinical studies, the most common
side effects of SPINRAZA included
lower respiratory infection, fever,
constipation, headache, vomiting,
back pain, and post-lumbar puncture
syndrome (headache related to the
“Some lab tests were run when Ashley first started SPINRAZA and again before each dose to monitor her blood and kidneys as recommended by her doctor.”